Form 4 for LXEO Lexeo Therapeutics, Inc.
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0001415889-25-005109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-19 | LXEO | Adler Eric | Chief Medical Off | S - Sale | $4.41 | -2,359 | 68.3K | -3% | -$10.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | S | D | 2,359 | $4.41 | 68,266 | D | — | — | (F2) Includes 63,906 RSUs. |